Uncategorized's votes

Title Vote type Value Timestampsort ascending
The story of the cancer medicine Ukrain and Wassil Nowicky percent 60 1 week ago
Phase I adjuvant trial of multi-epitope p53 vaccine for patients with squamous cell carcinoma of the head and neck (SCCHN): A pr percent 40 2 months ago
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? percent 100 2 months ago
Todoxin, the immune stimulant from Serbia percent 10 5 months ago
Todoxin against AIDS/HIV percent 10 5 months ago
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? percent 90 6 months ago
Circulating endothelial-cell kinetics and viability predict survival in breast cancer patients receiving metronomic chemotherapy percent 10 6 months ago
Todoxin, the immune stimulant from Serbia percent 100 8 months ago
Stories percent 70 10 months ago
A Natural Tallberg compund? percent 60 11 months ago
Ukrain treatment of a patient with retroperitoneal synovial sarcoma. percent 40 11 months ago
Ukrain percent 70 11 months ago
Low dose "Metronomic" Chemotherapy percent 100 11 months ago
Low dose "Metronomic" Chemotherapy percent 100 1 year ago
Albarin, Injectable Aloe Vera or Polymannons percent 100 1 year ago
Low dose "Metronomic" Chemotherapy percent 40 1 year ago
Metformin in the treatment of Cancer percent 90 1 year ago
Gut microbes and the brain: paradigm shift in neuroscience. percent 100 1 year ago
GcMAF-The cancer revolution from Japan percent 90 1 year ago
Metformin in the treatment of Cancer percent 90 2 years ago
A comparative evaluation of the influence of the complex drug Ukrain and its components on the effects of radiation percent 70 2 years ago
GcMAF-The cancer revolution from Japan percent 90 2 years ago
Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized clinical controlled trial of efficacy percent 100 2 years ago
Low dose "Metronomic" Chemotherapy percent 100 2 years ago
Low dose "Metronomic" Chemotherapy percent 100 3 years ago
Low dose "Metronomic" Chemotherapy percent 100 3 years ago
Low dose "Metronomic" Chemotherapy percent 100 3 years ago
Low dose "Metronomic" Chemotherapy percent 100 3 years ago
Low dose "Metronomic" Chemotherapy percent 100 3 years ago
Psorinum, the anti cancer miracle from India. percent 10 3 years ago
Low dose "Metronomic" Chemotherapy percent 100 3 years ago
Low dose "Metronomic" Chemotherapy percent 90 3 years ago
82 year old man with prostate cancer percent 90 3 years ago
Low dose "Metronomic" Chemotherapy percent 40 3 years ago
Psorinum, the anti cancer miracle from India. percent 100 3 years ago
Psorinum, the anti cancer miracle from India. percent 100 3 years ago
Low dose "Metronomic" Chemotherapy percent 100 3 years ago
Herbal Based Cancer Therapies percent 10 3 years ago
Low dose "Metronomic" Chemotherapy percent 90 3 years ago
71 year old woman, Pancraetic cancer with liver and lung metastasis. percent 80 3 years ago
Albarin, Injectable Aloe Vera or Polymannons percent 100 3 years ago
Ukrain percent 40 3 years ago
GcMAF-The cancer revolution from Japan percent 100 3 years ago
Metformin in the treatment of Cancer percent 100 3 years ago
Ukrain: general information, physical, chemical and biological properties percent 30 3 years ago
RECURRENCE OF BRAIN TUMORS MAY BE PREVENTED WITH RUTA AND CALCAREA PHOSPHORICA percent 90 3 years ago
Low-dose naltrexone for disease prevention and quality of life. percent 90 4 years ago
Todoxin against AIDS/HIV percent 100 4 years ago
A lipoxygenase inhibitor in breast cancer brain metastases. percent 80 4 years ago
Cellular immune suppression in cancer patients and its implication for dendritic cell therapy. percent 90 4 years ago
Metformin in the treatment of Cancer percent 100 4 years ago
Why is not Ukrain approved yet in Austria/EU? percent 100 4 years ago
Psorinum, the anti cancer miracle from India. percent 100 4 years ago
Psorinum, the anti cancer miracle from India. percent 100 4 years ago
Low dose "Metronomic" Chemotherapy percent 70 4 years ago
Metformin in the treatment of Cancer percent 100 4 years ago
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? percent 100 4 years ago
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? percent 100 4 years ago
Psorinum, the anti cancer miracle from India. percent 70 4 years ago
Psorinum, the anti cancer miracle from India. percent 100 4 years ago
Opioid growth factor improves clinical benefit and survival in patients with advanced pancreatic cancer. percent 10 4 years ago
This study provides a lot of valuable info in the full text version percent 10 4 years ago
Repeated transarterial chemoembolisation using different chemotherapeutic drug combinations followed by MR-guided laser-induced percent 100 4 years ago
Mikael Nordfors, fighting for independent medicine and a subject of "Honor Killings" percent 100 4 years ago
Why is not Ukrain approved yet in Austria/EU? percent 100 4 years ago
Background percent 70 4 years ago
Psorinum, the anti cancer miracle from India. percent 100 4 years ago
Why is not Ukrain approved yet in Austria/EU? percent 100 4 years ago
Ukrain (NSC-631570) in the treatment of pancreas cancer. percent 100 4 years ago
Psorinum, the anti cancer miracle from India. percent 70 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Cancer Psychotherapy according to Dr. Frederick B Levenson percent 40 5 years ago
Melatonin percent 10 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 90 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Bio-Immune therapy according to Professor Thomas Tallberg, a cure for Melanoma? percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Todoxin, the immune stimulant from Serbia percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
The anti-angiogenic basis of metronomic chemotherapy. percent 80 5 years ago
Metformin in the treatment of Cancer percent 100 5 years ago
Low dose "Metronomic" Chemotherapy percent 70 5 years ago
Low dose "Metronomic" Chemotherapy percent 100 5 years ago
Metformin in the treatment of Cancer percent 80 5 years ago
GcMAF-The cancer revolution from Japan percent 10 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Todoxin, the immune stimulant from Serbia percent 100 5 years ago
GcMAF-The cancer revolution from Japan percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 20 5 years ago
Oral metronomic chemotherapy using cyclophosphamide in metastatic patients (pts) after standard treatment: Results of a randomiz percent 10 5 years ago
GcMAF-The cancer revolution from Japan percent 100 5 years ago
Mikael Nordfors, fighting for independent medicine and a subject of "Honor Killings" percent 10 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Low dose "Metronomic" Chemotherapy percent 100 5 years ago
Metformin in the treatment of Cancer percent 30 5 years ago
Chelidonium majus L. (Ukrain) in the treatment of cancer patients. percent 10 5 years ago
Todoxin, the immune stimulant from Serbia percent 100 5 years ago
Bevacizumab for recurrent ependymoma. percent 70 5 years ago
GcMAF-The cancer revolution from Japan percent 100 5 years ago
GcMAF-The cancer revolution from Japan percent 30 5 years ago
GcMAF-The cancer revolution from Japan percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up. percent 100 5 years ago
The story of "Miracle Mineral" and Jim Humble percent 100 5 years ago
Cancer Psychotherapy according to Dr. Frederick B Levenson percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
GcMAF-The cancer revolution from Japan percent 100 5 years ago
Todoxin, the immune stimulant from Serbia percent 100 5 years ago
Hypericine percent 100 5 years ago
Hypericine percent 100 5 years ago
Todoxin, the immune stimulant from Serbia percent 100 5 years ago
Cystatin C in LS lymphosarcoma and HA-1 hepatoma treated with Ukrain and cyclophosphamide and involvement of apoptosis. percent 90 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Todoxin, the immune stimulant from Serbia percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Why is not Ukrain approved yet in Austria/EU? percent 100 5 years ago
Low dose carboplatin combined with angiostatic agents prevents metastasis in human testicular germ cell tumor xenografts. percent 60 5 years ago
Why is not Ukrain approved yet in Austria/EU? percent 100 5 years ago
Blinding Problem with mistletoe percent 100 5 years ago
Albarin, Injectable Aloe Vera or Polymannons percent 100 5 years ago
GcMAF-The cancer revolution from Japan percent 100 5 years ago
GcMAF-The cancer revolution from Japan percent 100 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Mikael Nordfors, fighting for independent medicine and a subject of "Honor Killings" percent 90 5 years ago
Psorinum, the anti cancer miracle from India. percent 100 5 years ago
Impressive survival data with semimetronomic oral chemotherapy with old agents in heavily treated metastatic breast cancer..... percent 60 6 years ago
Psorinum, the anti cancer miracle from India. percent 100 6 years ago
Metformin in the treatment of Cancer percent 10 6 years ago
GcMAF-The cancer revolution from Japan percent 100 6 years ago
Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. percent 100 6 years ago
Mikael Nordfors, fighting for independent medicine and a subject of "Honor Killings" percent 100 6 years ago
Clinical Investigations on Ukrain percent 90 6 years ago
GcMAF-The cancer revolution from Japan percent 100 6 years ago
The story of the cancer medicine Ukrain and Wassil Nowicky percent 30 6 years ago
Mistletoe Therapy in Cancer percent 60 6 years ago
Regulatory status and marketing history of Ukrain percent 10 6 years ago
The story of the cancer medicine Ukrain and Wassil Nowicky percent 80 6 years ago
The story of the cancer medicine Ukrain and Wassil Nowicky percent 80 6 years ago
The story of the cancer medicine Ukrain and Wassil Nowicky percent 100 6 years ago
The story of the cancer medicine Ukrain and Wassil Nowicky percent 40 6 years ago
The story of the cancer medicine Ukrain and Wassil Nowicky percent 50 6 years ago
The story of the cancer medicine Ukrain and Wassil Nowicky percent 20 6 years ago
The story of the cancer medicine Ukrain and Wassil Nowicky percent 30 6 years ago
The story of the cancer medicine Ukrain and Wassil Nowicky percent 10 6 years ago
Variations of the piriformis and sciatic nerve with clinical consequence: a review percent 100 6 years ago
Psorinum therapy in treating stomach, gall bladder, pancreatic, and liver cancers: a prospective clinical study. percent 100 6 years ago
Psorinum therapy in treating stomach, gall bladder, pancreatic, and liver cancers: a prospective clinical study. percent 100 6 years ago
DCA percent 100 6 years ago
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced non-s percent 100 6 years ago
Ukrain percent 100 6 years ago
Ukrain percent 10 6 years ago
Ukrain percent 100 6 years ago
Ukrain percent 10 6 years ago
Ukrain percent 100 6 years ago
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced non-s percent 100 6 years ago
Removed from Pubmed because of suspiion of scientific fraud: Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. percent 100 6 years ago
Biophotonics in the infrared spectral range reveal acupuncture meridian structure of the body. percent 90 6 years ago
Metabolic-targeted therapy with dichloroacetate (DCA): a novel treatment strategy to improve the outcome of photodynamic therapy percent 90 6 years ago
Systems biology: a therapeutic target for tumor therapy. percent 100 6 years ago
Artemisinin derivates in the treatment of Cancer percent 100 6 years ago
Mikael Nordfors, fighting for independent medicine and a subject of "Honor Killings" percent 90 6 years ago
The story of the cancer medicine Ukrain and Wassil Nowicky percent 100 6 years ago
Systems biology: a therapeutic target for tumor therapy. percent 80 6 years ago
Removed from Pubmed because of suspiion of scientific fraud: Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF. percent 90 6 years ago
Removed from Pubmed because of suspicion of scientific fraud: Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF). percent 100 6 years ago
The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. percent 80 6 years ago
Ukrain percent 50 7 years ago
Propolis Extract (Bio 30) Suppresses the Growth of Human Neurofibromatosis (NF) Tumor Xenografts in Mice percent 40 7 years ago
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced non-s percent 100 7 years ago
A phase II, single-arm clinical trial involving an alternative cancer treatment psorinum therapy in patients with advanced non-s percent 100 7 years ago
Dose-Dense and/or Metronomic Schedules of Specific Chemotherapies Consolidate the Chemosensitivity of Triple-Negative Breast Can percent 10 7 years ago
Ukrain: general information, physical, chemical and biological properties percent 100 7 years ago
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. percent 80 7 years ago
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid percent 60 7 years ago
Does the Ukrain preparation protect mice against lethal doses of bacteria? percent 60 7 years ago
The influence of the novel drug Ukrain on hemo- and immunopoiesis at the time of its maximum radioprotective effect percent 60 7 years ago
Ukrain (NSC-631570) in the treatment of pancreas cancer. percent 90 7 years ago
NF-kappaB does not influence the induction of apoptosis by Ukrain. percent 80 7 years ago
Dose-Dense and/or Metronomic Schedules of Specific Chemotherapies Consolidate the Chemosensitivity of Triple-Negative Breast Can percent 100 7 years ago
Low dose "Metronomic" Chemotherapy percent 90 7 years ago
Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate c percent 100 7 years ago
Boswellic acids: biological actions and molecular targets. percent 80 7 years ago
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer. percent 100 7 years ago
Clinical and Pharmacodynamic Evaluation of Metronomic Cyclophosphamide, Celecoxib, and Dexamethasone in Advanced Hormone-refract percent 80 8 years ago
Dichloroacetic acid percent 100 8 years ago
Democracy 2.1 How to Make a Bunch of Lazy and Selfish People Work Together? A handbook about collective Intelligence in Politics percent 100 8 years ago
Dichloroacetic acid percent 70 8 years ago
Evaluation of recombinant bacillus Calmette-Guerin expressing pertussis toxin in bladder cancer. percent 40 8 years ago
Controlled clinical evaluations of chlorine dioxide, chlorite and chlorate in man. percent 70 8 years ago
Adjuvant vaccination with melanoma antigen pulsed dendritic cells (DCs) in stage III melanoma patients. percent 80 8 years ago
Phase II study of docetaxel-prednisone (DP) in combination with metronomic cyclophosphamide (CTX) and celecoxib (C) ...... percent 90 8 years ago